Geron GERN
NASDAQ GERN
$1.12 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Geron (GERN) Gains from Sales and Divestitures (2010 - 2017)

Updated

Geron (GERN) recorded Gains from Sales and Divestitures of $1.23 million in FY2021, up 733.1% from $148,000 in FY2020.

Analysis

Geron (GERN) Gains from Sales and Divestitures (2010 - 2017) Analysis & Trends

Starting with FY2009, Geron's Gains from Sales and Divestitures history includes 10 years.

  • Annual Gains from Sales and Divestitures has a five-year compound annual growth rate of 138.4% (FY2016 to FY2021).
  • The FY2021 figure is the highest annual Gains from Sales and Divestitures in data going back to FY2009.
  • Per Business Quant data, GERN's Gains from Sales and Divestitures was $148,000 in FY2020 and -$5,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Geron 719.57 Mn -632.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -5,000.00
Dec 31, 2013 72,000.00
Sep 30, 2013 643,000.00
Jun 30, 2013 12,000.00
Mar 31, 2013 104,000.00
Dec 31, 2012 110,000.00
Sep 30, 2012 18,000.00
Dec 31, 2011 -5,000.00
Dec 31, 2010 -22,000.00
API Access

Geron Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=GERN&period=max&api_key=YOUR_API_KEY